Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CDK5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Cyclin-Dependent Kinase 5 (CDK5) is a unique member of the CDK family that lacks a role in cell cycle regulation and is not activated by cyclins. Instead, CDK5 is activated by neuron-specific partners p35 and p39, which are expressed primarily in post-mitotic neurons. CDK5 phosphorylates numerous substrates including tau, APP, presenilins, and NMDA receptors, making it a critical regulator of neuronal function. In Alzheimer's disease and other neurodegenerative conditions, dysregulation of CDK5 occurs due to calpain-mediated cleavage of p35 to p25, leading to hyperactivation of CDK5 and hyperphosphorylation of tau at multiple AD-relevant epitopes. CDK5-mediated tau phosphorylation contributes to neurofibrillary tangle formation and granulovacuolar degeneration, both hallmarks of AD pathology. CDK5 also plays roles in synaptic plasticity, learning and memory, and motor neuron survival. While CDK5 inhibitors have been explored therapeutically, their lack of specificity and neural toxicity have been significant obstacles.
No AI portrait yet
| Gene Symbol | CDK5 |
| Protein Family | CMGC kinase group, CDK family |
| Protein Type | Serine/Threonine Kinase |
| Function | Cdk5 knockout mice die at birth with severe cortical layering defects due to failed neuronal migration. |
| Primary Expression | Cytoplasm, nucleus, synapses, growth cones, perinuclear region |
| Amino Acids | 291 aa |
| Pathways | Apoptosis, Autophagy, Checkpoint Inhibitor, Immune Checkpoint, Immune Response |
| GeneCards | CDK5 |
| Human Protein Atlas | CDK5 |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer's disease, Ataxia |
| Known Drugs/Compounds | metformin, METFORMIN, N-ACETYLCYSTEINE, Protopanaxatriol, RESVERATROL |
| Interactions | ABETA, ACHE, Actin, AD, AGING, AKT |
| SciDEX Hypotheses | CDK5 Inhibition at Presynaptic Terminals Prevents |
| KG Connections | 750 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CDK5["CDK5"] -.->|"inhibits"| BECN1["BECN1"]
CDK5["CDK5"] -->|"interacts"| Ms["Ms"]
CDK5["CDK5"] -->|"activates"| Als["Als"]
CDK5["CDK5"] -->|"therapeutic target"| Alzheimer["Alzheimer"]
CDK5["CDK5"] -.->|"inhibits"| Neurodegeneration["Neurodegeneration"]
CDK5["CDK5"] -->|"activates"| Ms_1["Ms"]
DCX["DCX"] -->|"interacts"| CDK5["CDK5"]
PAFAH1B1["PAFAH1B1"] -->|"interacts"| CDK5["CDK5"]
DAB1["DAB1"] -->|"interacts"| CDK5["CDK5"]
LIS1["LIS1"] -->|"interacts"| CDK5["CDK5"]
style CDK5 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:CDK5 | data_in | dataset_row | 0.00 |
| benchmark_ot_ad_answer_key:CDK5 | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| Tau aggregation | mediates | process | 0.90 |
| NEURONAL MIGRATION | regulates | entity | 0.85 |
| Hyperthyroidism | associated_with | disease | 0.85 |
| Alzheimer's disease | involved_in | disease | 0.85 |
| Neurodegeneration | associated_with | disease | 0.80 |
| p25 | activates | protein | 0.80 |
| cell cycle | regulates | biological_process | 0.80 |
| mitochondrial_division | induces | biological_process | 0.80 |
| Als | activates | disease | 0.75 |
| Alzheimer | therapeutic_target | disease | 0.75 |
| PARKINSON'S DISEASE | associated_with | disease | 0.75 |
| Nucleokinesis | involved_in | process | 0.75 |
| Als | expressed_in | disease | 0.75 |
| TREM2 | activates | gene | 0.70 |
| CREB | activates | gene | 0.70 |
| GSK3B | inhibits | gene | 0.70 |
| TAU | expresses | gene | 0.70 |
| CREB | inhibits | gene | 0.70 |
| PSEN1 | expresses | gene | 0.70 |
| NEURONS | expresses | cell_type | 0.70 |
| GFAP | regulates | gene | 0.70 |
| TNF | activates | gene | 0.70 |
| ENDOTHELIAL | activates | cell_type | 0.70 |
| UNFOLDED PROTEIN RESPONSE | activates | pathway | 0.70 |
| PSEN2 | associated_with | gene | 0.70 |
| NEURODEGENERATION | associated_with | phenotype | 0.70 |
| GSK3 | associated_with | gene | 0.70 |
| synaptic dysfunction | causes | phenotype | 0.70 |
| BECN1 | inhibits | protein | 0.70 |
| tau | phosphorylates | protein | 0.70 |
| Wnt signaling | participates_in | pathway | 0.70 |
| GSK3 | activates | gene | 0.70 |
| MACROPHAGE | regulates | cell_type | 0.65 |
| TAU | associated_with | protein | 0.65 |
| MACROPHAGE | activates | cell_type | 0.65 |
| mitochondria | co_discussed | concept | 0.65 |
| TAU PHOSPHORYLATION | regulates | phenotype | 0.65 |
| APOPTOSIS | interacts_with | phenotype | 0.65 |
| NEUROINFLAMMATION | causes | phenotype | 0.65 |
| Ms | associated_with | disease | 0.65 |
| apoptosis | co_discussed | concept | 0.65 |
| INFLAMMATION | activates | phenotype | 0.65 |
| INFLAMMATION | treats | phenotype | 0.65 |
| NEUROINFLAMMATION | inhibits | phenotype | 0.65 |
| NEURODEGENERATION | protects_against | disease | 0.65 |
| SYNAPTIC PLASTICITY | activates | phenotype | 0.65 |
| MITOPHAGY | inhibits | phenotype | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:CDK5 | data_in | dataset_row | 0.00 |
| benchmark_ot_ad_answer_key:CDK5 | data_in | dataset_row | 0.00 |
| entities-overview | associated_with | wiki | 0.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| Protopanaxatriol | inhibits | compound | 0.90 |
| Hyperthyroidism | upregulates | disease | 0.85 |
| ABETA | activates | protein | 0.80 |
| E2F1 | regulates | gene | 0.80 |
| RESVERATROL | modulates | drug | 0.75 |
| BDNF | associated_with | gene | 0.70 |
| AMYOTROPHIC LATERAL SCLEROSIS | activates | disease | 0.70 |
| APP | expresses | gene | 0.70 |
| ADAM10 | expresses | gene | 0.70 |
| AMPK | inhibits | gene | 0.70 |
| ACHE | inhibits | gene | 0.70 |
| BDNF | expressed_in | gene | 0.70 |
| APP | causes | gene | 0.70 |
| TAU | associated_with | protein | 0.70 |
| TAU | activates | protein | 0.70 |
| SOD1 | treats | gene | 0.65 |
| METFORMIN | inhibits | drug | 0.65 |
| GABA | interacts_with | phenotype | 0.65 |
| NEURONS | inhibits | cell_type | 0.65 |
| NEURONS | regulates | cell_type | 0.65 |
| APOPTOSIS | treats | phenotype | 0.65 |
| NEURONS | causes | cell_type | 0.65 |
| BACE1 | expressed_in | gene | 0.65 |
| AKT | expressed_in | gene | 0.65 |
| N-ACETYLCYSTEINE | treats | drug | 0.65 |
| OXIDATIVE STRESS | activates | phenotype | 0.65 |
| N-ACETYLCYSTEINE | inhibits | drug | 0.65 |
| AMPK | activates | gene | 0.65 |
| AMPK | regulates | gene | 0.65 |
| AMPK | phosphorylates | gene | 0.65 |
| AMPK | causes | gene | 0.65 |
| N-ACETYLCYSTEINE | activates | drug | 0.65 |
| CALCIUM SIGNALING | regulates | pathway | 0.65 |
| BDNF | co_discussed | gene | 0.65 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.64 |
| TAU TANGLES | inhibits | gene | 0.60 |
| AUTOPHAGY | inhibits | gene | 0.60 |
| NEURODEGENERATION | inhibits | gene | 0.60 |
| NEURON | causes | gene | 0.60 |
| AXON | causes | gene | 0.60 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| MITOCHONDRIA | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| CDK5 Inhibition at Presynaptic Terminals Prevents Activity-D | 0.640 | neurodegeneration | Investigate prion-like spreading of tau |
| Aβ42 oligomers drive TDP-43 phosphorylation at s409/410 thro | 0.595 | neurodegeneration | What mechanisms drive TDP-43 pathology s |
| A post-trigger CDK5-dominant kinase feedback loop maintains | 0.590 | neurodegeneration | Does tau dendritic missorting persist in |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 9 hypotheses Top: 0.914
neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.640
neurodegeneration | 2026-04-04 | 15 hypotheses Top: 0.814
neurodegeneration | 2026-04-03 | 44 hypotheses Top: 0.990
neuroscience | 2026-04-03 | 67 hypotheses Top: 1.000
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.73 · 2026-04-22
closed · Rounds: 4 · Score: 0.90 · 2026-04-12
closed · Rounds: 4 · Score: 0.95 · 2026-04-10
closed · Rounds: 4 · Score: 0.89 · 2026-04-06
closed · Rounds: 3 · Score: 0.95 · 2026-04-04
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
Hypotheses and analyses mentioning CDK5 in their description or question text
No additional research found